Biotech

All Articles

Lilly- backed weight-loss biotech files IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has filed to ...

Aelis' cannabis use medication fails phase 2b, steering Indivior to reassess $100M choice

.Aelis Farma's hopes of protecting a simple, favorable selection on a $100 million choice settlement...

ProKidney standstills period 3 trial certainly not needed to have for tissue therapy approval

.ProKidney has quit among a set of stage 3 tests for its tissue treatment for renal ailment after de...

Vaxcyte surges on 'sensational' 31-valent PCV gain against Pfizer

.Vaxcyte unveiled what professionals referred to as "sensational" phase 1/2 information for its own ...

Recursion's brain condition trial reveals insufficient documentation of efficacy

.Recursion has actually discovered with a very early test of its own tech-enabled method to medicati...

Acepodia, Pfizer click on together for chemistry-based tissue treatment

.Call it a case of excellent chemistry: Acepodia, a biotech based on Nobel Champion science, is part...

Praxis epilepsy drug minimizes seizures in period 2 litigation

.Praxis Precision Medicines has scored yet another midphase win in epilepsy this year, along with it...

Three execs surrender as Dyne blog posts blended data for DMD applicant

.After escaping a medical grip a number of years back, Dyne Therapy has actually revealed brand-new ...

Arrowhead fires off period 3 records in uncommon metabolic health condition ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its own hand before a prospective showdown with Io...

Pfizer, Valneva reveal lyme disease shot reliable for second enhancer

.Pfizer and Valneva might have concerning pair of more years to stand by just before they create the...